Nusayba Bagegni, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    OncLive/MJH Life Sciences
    Topic:
    Current and Emerging Trends in Breast Cancer: HER2- Positive and HER-Low: An OncLive Scientific Interchange and Workshop
    Date added:
    02/21/2023
    Date updated:
    02/21/2024
    Relationship end date:
    12/14/2021
Return to Central Illinois Hematology Oncology Conference: Emphasis on Precision-Guided Management